Lionel Apetoh mainly investigates Immune system, Cancer research, Immunology, Immunogenic cell death and Cancer cell. Lionel Apetoh works in the field of Immune system, focusing on Immunogenicity in particular. His Cancer research study incorporates themes from Inflammasome, Antibiotics, Chemotherapy, CD8 and Adoptive cell transfer.
His Immunology research is multidisciplinary, incorporating perspectives in Cancer, Cytotoxic T cell, Cyclophosphamide and Myeloid-derived Suppressor Cell. Lionel Apetoh works mostly in the field of Immunogenic cell death, limiting it down to topics relating to Antigen and, in certain cases, Radiation therapy, as a part of the same area of interest. His work deals with themes such as Cell, Innate immune system and Cell biology, which intersect with Cancer cell.
Lionel Apetoh mainly focuses on Immune system, Immunology, Cancer research, Cancer and Cell biology. The Immune system study combines topics in areas such as Cancer cell and Cytotoxic T cell. His study focuses on the intersection of Immunology and fields such as Chemotherapy with connections in the field of Oncology, Breast cancer, Immune checkpoint inhibitors and Tumor cells.
His research in Cancer research intersects with topics in Immune checkpoint, Inflammasome, Dendritic cell and Radiation therapy. His work in the fields of Cell biology, such as STAT3, intersects with other areas such as Calreticulin. As a part of the same scientific study, he usually deals with the Immunogenic cell death, concentrating on Cisplatin and frequently concerns with Oxaliplatin.
His scientific interests lie mostly in Cancer research, Immune system, Cancer, T cell and Cell biology. His Cancer research research integrates issues from Cancer cell, Inflammation, Secretion and Immune checkpoint. His Immune system study combines topics from a wide range of disciplines, such as Autophagy and Radiation therapy.
His Cancer research incorporates themes from Microbiome and Chemotherapy. His T cell research includes elements of Acquired immune system, Cell and Innate immune system. His Cell biology study combines topics in areas such as Apoptosis and THP1 cell line.
His primary areas of investigation include Cell biology, Immunotherapy, Autophagy, Immune system and Innate immune system. Lionel Apetoh has included themes like THP1 cell line, Activator and CARD domain in his Cell biology study. His Immunotherapy research is multidisciplinary, relying on both Cancer cell, Lung cancer and Cisplatin.
Lionel Apetoh interconnects Computational biology and Programmed cell death in the investigation of issues within Autophagy. Much of his study explores Immune system relationship to Cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid.
Nature Medicine (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;François Ghiringhelli;François Ghiringhelli;François Ghiringhelli;Gian Maria Fimia.
Nature Medicine (2007)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi;Lionel Apetoh;Jenna M. Sullivan;Bruce R. Blazar.
Journal of Experimental Medicine (2010)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric.
Nature Medicine (2009)
Immunological aspects of cancer chemotherapy.
Laurence Zitvogel;Lionel Apetoh;Lionel Apetoh;François Ghiringhelli;Guido Kroemer;Guido Kroemer.
Nature Reviews Immunology (2008)
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki.
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
Julie Vincent;Grégoire Mignot;Fanny Chalmin;Sylvain Ladoire.
Cancer Research (2010)
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin;Sylvain Ladoire;Grégoire Mignot;Julie Vincent.
Journal of Clinical Investigation (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin.
A. Tesniere;F. Schlemmer;F. Schlemmer;F. Schlemmer;V. Boige;O. Kepp;O. Kepp;O. Kepp.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: